Ertapenem is a carbapenem antibiotic marketed by Merck as Invanz. It is structurally very similar to meropenem in that it possess a 1-β-methyl group.
Read more about Ertapenem: Indications, Dosage, Pharmacokinetics, Side Effects
Ertapenem is a carbapenem antibiotic marketed by Merck as Invanz. It is structurally very similar to meropenem in that it possess a 1-β-methyl group.
Read more about Ertapenem: Indications, Dosage, Pharmacokinetics, Side Effects